查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1812378

藥械組合產品市場

Drug-device Combination Products Market
出版日期: | 出版商: Transparency Market Research | 英文 242 Pages | 商品交期: 2-10個工作天內

價格

藥物-設備組合產品市場-報告範圍

TMR 的全球藥械組合產品市場報告研究了過去和當前的成長趨勢和機遇，以獲得 2025 年至 2035 年預測期內市場指標的寶貴見解。該報告提供了 2025 年至 2035 年期間全球藥械組合產品市場的收入，以 2025 年為基準年，2035 年為預測年。該報告還提供了 2025 年至 2035 年期間全球藥械組合產品市場的年複合成長率(CAGR %)。

本報告經過廣泛的研究後編寫。主要研究工作量較大，分析師訪問了關鍵意見領袖、產業領袖和輿論領袖。次要研究則參考了主要廠商的產品資料、年度報告、新聞稿和相關文件，以了解二輪車導航顯示器市場。

市場概況
2024年的市場價值 2521億美元
2035年的市場價值 6486億美元
複合年成長率 9.5%

本報告深入探討了全球二輪車導航顯示器市場的競爭格局。該報告確定了全球藥械組合產品市場的主要參與者，並根據其各項屬性對每個參與者進行了分析。本報告對全球藥械組合產品市場參與者的屬性進行了分析，涵蓋公司概況、財務狀況、近期發展和 SWOT 分析。

目錄

第1章：前言

第2章：假設與研究方法

第3章：執行摘要：全球市場

第4章：市場概況

  • 介紹
  • 概述
  • 市場動態
  • 2020年至2035年全球藥物-器材組合產品市場分析與預測

第5章：關鍵見解

  • 主要地區/國家的監管格局
  • 市場趨勢
  • 波特五力分析
  • PESTEL分析
  • 最終用戶的關鍵購買指標
  • 品牌和定價分析
  • 價值鏈分析
  • 技術進步

第6章：全球市場分析與預測：依產品類型

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2035 年按產品類型分類的市場價值預測
    • 注射藥物輸送裝置
      • 筆式注射器
      • 自動注射器
      • 預充式注射器
      • 其他
    • 點滴幫浦
      • 體積
      • 注射器
      • 門診
      • 可植入
      • 胰島素
      • 其他
    • 骨科組合產品
      • 骨移植植入物
      • 抗生素骨水泥
    • 透皮貼劑
    • 藥物洗脫支架
      • 周邊血管支架
      • 藥物洗脫支架
    • 吸入器
      • 乾粉
      • 霧化器
      • 定量給藥
    • 其他
  • 按產品類型分類的市場吸引力

第7章：全球市場分析與預測：按應用

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2035 年各應用市場價值預測
    • 糖尿病管理
    • 呼吸系統疾病
    • 眼部疾病
    • 自體免疫疾病
    • 癌症
    • 疼痛管理
    • 傳染病
    • 心血管疾病
    • 肥胖管理
    • 其他
  • 按應用分類的市場吸引力

第8章：全球市場分析與預測：按最終用戶

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2035 年終端用戶市場價值預測
    • 醫院
    • 診所
    • 門診手術中心
    • 居家護理中心
    • 其他
  • 最終用戶的市場吸引力

第9章：全球市場分析與預測：按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 各地區市場吸引力

第10章：北美市場分析與預測

  • 美國
  • 加拿大

第 11 章：歐洲市場分析與預測

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 瑞士
  • 荷蘭
  • 歐洲其他地區

第 12 章：亞太市場分析與預測

  • 中國
  • 日本
  • 印度
  • 澳洲和紐西蘭
  • 韓國
  • 亞太其他地區

第13章：拉丁美洲市場分析與預測

  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區

第 14 章：中東和非洲市場分析與預測

  • 海灣合作理事會國家
  • 南非
  • 中東和非洲其他地區

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 各公司市佔率分析（2024年）
  • 公司簡介
    • Abbott
    • Eli Lilly and Company
    • Medtronic
    • Novo Nordisk A/S
    • Novartis AG
    • Sanofi
    • Boston Scientific Corporation or its affiliates.
    • BD
    • Merck KGaA
    • B. Braun SE
    • Stryker
    • Gerresheimer AG
    • Narang Medical Limited.
    • Sparsha Pharma International Pvt Ltd
    • Other Prominent Players
Product Code: TMRGL1534

Drug-device Combination Products Market - Scope of Report

TMR's report on the global Drug-device Combination Products Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Drug-device Combination Products Market for the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Drug-device Combination Products Market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Drug-device Combination Products Market .

Market Snapshot
Market Value in 2024US$ 252.1 Bn
Market Value in 2035US$ 648.6 Bn
CAGR9.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Drug-device Combination Products Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Drug-device Combination Products Market . These serve as valuable tools for existing Market players as well as for entities interested in participating in the global Drug-device Combination Products Market .

The report delves into the competitive landscape of the global Drug-device Combination Products Market . Key players operating in the global Drug-device Combination Products Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Drug-device Combination Products Market profiled in this report.

Key Questions Answered in Global Drug-device Combination Products Market Report:

  • What are the opportunities in the global Drug-device Combination Products Market ?
  • What are the major drivers, restraints, opportunities, and threats in the Market ?
  • Which regional Market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the Market positions of different companies operating in the global Market ?

Drug-device Combination Products Market - Research Objectives and Research Approach

The comprehensive report on the global Drug-device Combination Products Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Drug-device Combination Products Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global Drug-device Combination Products Market .

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Drug-device Combination Products Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Drug-device Combination Products Market Analysis and Forecasts, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Regulatory Landscape across Key Regions / Countries
  • 5.2. Market Trends
  • 5.3. PORTER's Five Forces Analysis
  • 5.4. PESTEL Analysis
  • 5.5. Key Purchase Metrics for End-users
  • 5.6. Brand and Pricing Analysis
  • 5.7. Value Chain Analysis
  • 5.8. Technological Advancement

6. Global Drug-device Combination Products Market Analysis and Forecasts, By Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product Type, 2020 to 2035
    • 6.3.1. Injectable Drug Delivery Devices
      • 6.3.1.1. Pen Injectors
      • 6.3.1.2. Autoinjectors
      • 6.3.1.3. Pre-Filled Syringes
      • 6.3.1.4. Others
    • 6.3.2. Infusion Pumps
      • 6.3.2.1. Volumetric
      • 6.3.2.2. Syringes
      • 6.3.2.3. Ambulatory
      • 6.3.2.4. Implantable
      • 6.3.2.5. Insulin
      • 6.3.2.6. Others
    • 6.3.3. Orthopedic Combination Products
      • 6.3.3.1. Bone Graft Implants
      • 6.3.3.2. Antibiotic Bone Cement
    • 6.3.4. Transdermal Patches
    • 6.3.5. Drug Eluting Stents
      • 6.3.5.1. Peripheral Vascular Stents
      • 6.3.5.2. Drug Eluting Stents
    • 6.3.6. Inhalers
      • 6.3.6.1. Dry Powder
      • 6.3.6.2. Nebulizers
      • 6.3.6.3. Metered Dose
    • 6.3.7. Others
  • 6.4. Market Attractiveness By Product Type

7. Global Drug-device Combination Products Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020 to 2035
    • 7.3.1. Diabetes Management
    • 7.3.2. Respiratory Diseases
    • 7.3.3. Eye Diseases
    • 7.3.4. Autoimmune Diseases
    • 7.3.5. Cancer
    • 7.3.6. Pain Management
    • 7.3.7. Infectious Diseases
    • 7.3.8. Cardiovascular Diseases
    • 7.3.9. Obesity Management
    • 7.3.10. Others
  • 7.4. Market Attractiveness By Application

8. Global Drug-device Combination Products Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020 to 2035
    • 8.3.1. Hospitals
    • 8.3.2. Clinics
    • 8.3.3. Ambulatory Surgical Centers
    • 8.3.4. Home Care Centers
    • 8.3.5. Others
  • 8.4. Market Attractiveness By End-user

9. Global Drug-device Combination Products Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Region

10. North America Drug-device Combination Products Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Product Type, 2020 to 2035
    • 10.2.1. Injectable Drug Delivery Devices
      • 10.2.1.1. Pen Injectors
      • 10.2.1.2. Autoinjectors
      • 10.2.1.3. Pre-Filled Syringes
      • 10.2.1.4. Others
    • 10.2.2. Infusion Pumps
      • 10.2.2.1. Volumetric
      • 10.2.2.2. Syringes
      • 10.2.2.3. Ambulatory
      • 10.2.2.4. Implantable
      • 10.2.2.5. Insulin
      • 10.2.2.6. Others
    • 10.2.3. Orthopedic Combination Products
      • 10.2.3.1. Bone Graft Implants
      • 10.2.3.2. Antibiotic Bone Cement
    • 10.2.4. Transdermal Patches
    • 10.2.5. Drug Eluting Stents
      • 10.2.5.1. Peripheral Vascular Stents
      • 10.2.5.2. Drug Eluting Stents
    • 10.2.6. Inhalers
      • 10.2.6.1. Dry Powder
      • 10.2.6.2. Nebulizers
      • 10.2.6.3. Metered Dose
    • 10.2.7. Others
  • 10.3. Market Value Forecast By Application, 2020 to 2035
    • 10.3.1. Diabetes Management
    • 10.3.2. Respiratory Diseases
    • 10.3.3. Eye Diseases
    • 10.3.4. Autoimmune Diseases
    • 10.3.5. Cancer
    • 10.3.6. Pain Management
    • 10.3.7. Infectious Diseases
    • 10.3.8. Cardiovascular Diseases
    • 10.3.9. Obesity Management
    • 10.3.10. Others
  • 10.4. Market Value Forecast By End-user, 2020 to 2035
    • 10.4.1. Hospitals
    • 10.4.2. Clinics
    • 10.4.3. Ambulatory Surgical Centers
    • 10.4.4. Home Care Centers
    • 10.4.5. Others
  • 10.5. Market Value Forecast By Country, 2020 to 2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Drug-device Combination Products Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product Type, 2020 to 2035
    • 11.2.1. Injectable Drug Delivery Devices
      • 11.2.1.1. Pen Injectors
      • 11.2.1.2. Autoinjectors
      • 11.2.1.3. Pre-Filled Syringes
      • 11.2.1.4. Others
    • 11.2.2. Infusion Pumps
      • 11.2.2.1. Volumetric
      • 11.2.2.2. Syringes
      • 11.2.2.3. Ambulatory
      • 11.2.2.4. Implantable
      • 11.2.2.5. Insulin
      • 11.2.2.6. Others
    • 11.2.3. Orthopedic Combination Products
      • 11.2.3.1. Bone Graft Implants
      • 11.2.3.2. Antibiotic Bone Cement
    • 11.2.4. Transdermal Patches
    • 11.2.5. Drug Eluting Stents
      • 11.2.5.1. Peripheral Vascular Stents
      • 11.2.5.2. Drug Eluting Stents
    • 11.2.6. Inhalers
      • 11.2.6.1. Dry Powder
      • 11.2.6.2. Nebulizers
      • 11.2.6.3. Metered Dose
    • 11.2.7. Others
  • 11.3. Market Value Forecast By Application, 2020 to 2035
    • 11.3.1. Diabetes Management
    • 11.3.2. Respiratory Diseases
    • 11.3.3. Eye Diseases
    • 11.3.4. Autoimmune Diseases
    • 11.3.5. Cancer
    • 11.3.6. Pain Management
    • 11.3.7. Infectious Diseases
    • 11.3.8. Cardiovascular Diseases
    • 11.3.9. Obesity Management
    • 11.3.10. Others
  • 11.4. Market Value Forecast By End-user, 2020 to 2035
    • 11.4.1. Hospitals
    • 11.4.2. Clinics
    • 11.4.3. Ambulatory Surgical Centers
    • 11.4.4. Home Care Centers
    • 11.4.5. Others
  • 11.5. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Switzerland
    • 11.5.7. The Netherlands
    • 11.5.8. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Drug-device Combination Products Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product Type, 2020 to 2035
    • 12.2.1. Injectable Drug Delivery Devices
      • 12.2.1.1. Pen Injectors
      • 12.2.1.2. Autoinjectors
      • 12.2.1.3. Pre-Filled Syringes
      • 12.2.1.4. Others
    • 12.2.2. Infusion Pumps
      • 12.2.2.1. Volumetric
      • 12.2.2.2. Syringes
      • 12.2.2.3. Ambulatory
      • 12.2.2.4. Implantable
      • 12.2.2.5. Insulin
      • 12.2.2.6. Others
    • 12.2.3. Orthopedic Combination Products
      • 12.2.3.1. Bone Graft Implants
      • 12.2.3.2. Antibiotic Bone Cement
    • 12.2.4. Transdermal Patches
    • 12.2.5. Drug Eluting Stents
      • 12.2.5.1. Peripheral Vascular Stents
      • 12.2.5.2. Drug Eluting Stents
    • 12.2.6. Inhalers
      • 12.2.6.1. Dry Powder
      • 12.2.6.2. Nebulizers
      • 12.2.6.3. Metered Dose
    • 12.2.7. Others
  • 12.3. Market Value Forecast By Application, 2020 to 2035
    • 12.3.1. Diabetes Management
    • 12.3.2. Respiratory Diseases
    • 12.3.3. Eye Diseases
    • 12.3.4. Autoimmune Diseases
    • 12.3.5. Cancer
    • 12.3.6. Pain Management
    • 12.3.7. Infectious Diseases
    • 12.3.8. Cardiovascular Diseases
    • 12.3.9. Obesity Management
    • 12.3.10. Others
  • 12.4. Market Value Forecast By End-user, 2020 to 2035
    • 12.4.1. Hospitals
    • 12.4.2. Clinics
    • 12.4.3. Ambulatory Surgical Centers
    • 12.4.4. Home Care Centers
    • 12.4.5. Others
  • 12.5. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. South Korea
    • 12.5.6. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Drug-device Combination Products Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product Type, 2020 to 2035
    • 13.2.1. Injectable Drug Delivery Devices
      • 13.2.1.1. Pen Injectors
      • 13.2.1.2. Autoinjectors
      • 13.2.1.3. Pre-Filled Syringes
      • 13.2.1.4. Others
    • 13.2.2. Infusion Pumps
      • 13.2.2.1. Volumetric
      • 13.2.2.2. Syringes
      • 13.2.2.3. Ambulatory
      • 13.2.2.4. Implantable
      • 13.2.2.5. Insulin
      • 13.2.2.6. Others
    • 13.2.3. Orthopedic Combination Products
      • 13.2.3.1. Bone Graft Implants
      • 13.2.3.2. Antibiotic Bone Cement
    • 13.2.4. Transdermal Patches
    • 13.2.5. Drug Eluting Stents
      • 13.2.5.1. Peripheral Vascular Stents
      • 13.2.5.2. Drug Eluting Stents
    • 13.2.6. Inhalers
      • 13.2.6.1. Dry Powder
      • 13.2.6.2. Nebulizers
      • 13.2.6.3. Metered Dose
    • 13.2.7. Others
  • 13.3. Market Value Forecast By Application, 2020 to 2035
    • 13.3.1. Diabetes Management
    • 13.3.2. Respiratory Diseases
    • 13.3.3. Eye Diseases
    • 13.3.4. Autoimmune Diseases
    • 13.3.5. Cancer
    • 13.3.6. Pain Management
    • 13.3.7. Infectious Diseases
    • 13.3.8. Cardiovascular Diseases
    • 13.3.9. Obesity Management
    • 13.3.10. Others
  • 13.4. Market Value Forecast By End-user, 2020 to 2035
    • 13.4.1. Hospitals
    • 13.4.2. Clinics
    • 13.4.3. Ambulatory Surgical Centers
    • 13.4.4. Home Care Centers
    • 13.4.5. Others
  • 13.5. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Argentina
    • 13.5.4. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Drug-device Combination Products Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product Type, 2020 to 2035
    • 14.2.1. Injectable Drug Delivery Devices
      • 14.2.1.1. Pen Injectors
      • 14.2.1.2. Autoinjectors
      • 14.2.1.3. Pre-Filled Syringes
      • 14.2.1.4. Others
    • 14.2.2. Infusion Pumps
      • 14.2.2.1. Volumetric
      • 14.2.2.2. Syringes
      • 14.2.2.3. Ambulatory
      • 14.2.2.4. Implantable
      • 14.2.2.5. Insulin
      • 14.2.2.6. Others
    • 14.2.3. Orthopedic Combination Products
      • 14.2.3.1. Bone Graft Implants
      • 14.2.3.2. Antibiotic Bone Cement
    • 14.2.4. Transdermal Patches
    • 14.2.5. Drug Eluting Stents
      • 14.2.5.1. Peripheral Vascular Stents
      • 14.2.5.2. Drug Eluting Stents
    • 14.2.6. Inhalers
      • 14.2.6.1. Dry Powder
      • 14.2.6.2. Nebulizers
      • 14.2.6.3. Metered Dose
    • 14.2.7. Others
  • 14.3. Market Value Forecast By Application, 2020 to 2035
    • 14.3.1. Diabetes Management
    • 14.3.2. Respiratory Diseases
    • 14.3.3. Eye Diseases
    • 14.3.4. Autoimmune Diseases
    • 14.3.5. Cancer
    • 14.3.6. Pain Management
    • 14.3.7. Infectious Diseases
    • 14.3.8. Cardiovascular Diseases
    • 14.3.9. Obesity Management
    • 14.3.10. Others
  • 14.4. Market Value Forecast By End-user, 2020 to 2035
    • 14.4.1. Hospitals
    • 14.4.2. Clinics
    • 14.4.3. Ambulatory Surgical Centers
    • 14.4.4. Home Care Centers
    • 14.4.5. Others
  • 14.5. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. Abbott
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Eli Lilly and Company
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Medtronic
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Novo Nordisk A/S
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Novartis AG
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Sanofi
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Boston Scientific Corporation or its affiliates.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. BD
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Merck KGaA
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. B. Braun SE
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. Stryker
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Gerresheimer AG
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Narang Medical Limited.
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Product Portfolio
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. Sparsha Pharma International Pvt Ltd
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Product Portfolio
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments
    • 15.3.15. Other Prominent Players
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Financial Overview
      • 15.3.15.3. Product Portfolio
      • 15.3.15.4. Business Strategies
      • 15.3.15.5. Recent Developments

List of Tables

  • Table 01: Global Drug-device Combination Products Market Value (US$ Mn) Forecast, By Product Type, 2020 to 2035
  • Table 02: Global Drug-device Combination Products Market Value (US$ Mn) Forecast, By Application, 2020 to 2035
  • Table 03: Global Drug-device Combination Products Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
  • Table 04: Global Drug-device Combination Products Market Value (US$ Mn) Forecast, By Region, 2020 to 2035
  • Table 05: North America Drug-device Combination Products Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 06: North America Drug-device Combination Products Market Value (US$ Mn) Forecast, By Product Type, 2020 to 2035
  • Table 07: North America Drug-device Combination Products Market Value (US$ Mn) Forecast, By Application, 2020 to 2035
  • Table 08: North America Drug-device Combination Products Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
  • Table 09: Europe Drug-device Combination Products Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2035
  • Table 10: Europe Drug-device Combination Products Market Value (US$ Mn) Forecast, By Product Type, 2020 to 2035
  • Table 11: Europe Drug-device Combination Products Market Value (US$ Mn) Forecast, By Application, 2020 to 2035
  • Table 12: Europe Drug-device Combination Products Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
  • Table 13: Asia Pacific Drug-device Combination Products Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2035
  • Table 14: Asia Pacific Drug-device Combination Products Market Value (US$ Mn) Forecast, By Product Type, 2020 to 2035
  • Table 15 Asia Pacific Drug-device Combination Products Market Value (US$ Mn) Forecast, By Application, 2020 to 2035
  • Table 16: Asia Pacific Drug-device Combination Products Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
  • Table 17: Latin America Drug-device Combination Products Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2035
  • Table 18: Latin America Drug-device Combination Products Market Value (US$ Mn) Forecast, By Product Type, 2020 to 2035
  • Table 19: Latin America Drug-device Combination Products Market Value (US$ Mn) Forecast, By Application, 2020 to 2035
  • Table 20: Latin America Drug-device Combination Products Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
  • Table 21: Middle East & Africa Drug-device Combination Products Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2035
  • Table 22: Middle East & Africa Drug-device Combination Products Market Value (US$ Mn) Forecast, By Product Type, 2020 to 2035
  • Table 23: Middle East & Africa Drug-device Combination Products Market Value (US$ Mn) Forecast, By Application, 2020 to 2035
  • Table 24: Middle East & Africa Drug-device Combination Products Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035

List of Figures

  • Figure 01: Global Drug-device Combination Products Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 02: Global Drug-device Combination Products Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 03: Global Drug-device Combination Products Market Revenue (US$ Mn), by Injectable Drug Delivery Devices, 2020 to 2035
  • Figure 04: Global Drug-device Combination Products Market Revenue (US$ Mn), by Infusion Pumps, 2020 to 2035
  • Figure 05: Global Drug-device Combination Products Market Revenue (US$ Mn), By Orthopedic Combination Products, 2020 to 2035
  • Figure 06: Global Drug-device Combination Products Market Revenue (US$ Mn), By Transdermal Patches, 2020 to 2035
  • Figure 07: Global Drug-device Combination Products Market Revenue (US$ Mn), By Drug Eluting Stents, 2020 to 2035
  • Figure 08: Global Drug-device Combination Products Market Revenue (US$ Mn), By Inhalers, 2020 to 2035
  • Figure 09: Global Drug-device Combination Products Market Revenue (US$ Mn), By Others, 2020 to 2035
  • Figure 10: Global Drug-device Combination Products Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 11: Global Drug-device Combination Products Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 12: Global Drug-device Combination Products Market Revenue (US$ Mn), by Diabetes Management, 2020 to 2035
  • Figure 13: Global Drug-device Combination Products Market Revenue (US$ Mn), By Respiratory Diseases, 2020 to 2035
  • Figure 14: Global Drug-device Combination Products Market Revenue (US$ Mn), By Eye Diseases, 2020 to 2035
  • Figure 15: Global Drug-device Combination Products Market Revenue (US$ Mn), By Autoimmune Diseases, 2020 to 2035
  • Figure 16: Global Drug-device Combination Products Market Revenue (US$ Mn), By Cancer, 2020 to 2035
  • Figure 17: Global Drug-device Combination Products Market Revenue (US$ Mn), By Pain Management, 2020 to 2035
  • Figure 18: Global Drug-device Combination Products Market Revenue (US$ Mn), By Infectious Diseases, 2020 to 2035
  • Figure 19: Global Drug-device Combination Products Market Revenue (US$ Mn), By Cardiovascular Diseases, 2020 to 2035
  • Figure 20: Global Drug-device Combination Products Market Revenue (US$ Mn), By Obesity Management, 2020 to 2035
  • Figure 21: Global Drug-device Combination Products Market Revenue (US$ Mn), By Others, 2020 to 2035
  • Figure 22: Global Drug-device Combination Products Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 23: Global Drug-device Combination Products Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 24: Global Drug-device Combination Products Market Revenue (US$ Mn), by Hospitals, 2020 to 2035
  • Figure 25: Global Drug-device Combination Products Market Revenue (US$ Mn), By Clinics, 2020 to 2035
  • Figure 26: Global Drug-device Combination Products Market Revenue (US$ Mn), By Ambulatory Surgical Centers, 2020 to 2035
  • Figure 27: Global Drug-device Combination Products Market Revenue (US$ Mn), By Home Care Centers, 2020 to 2035
  • Figure 28: Global Drug-device Combination Products Market Revenue (US$ Mn), By Others, 2020 to 2035
  • Figure 29: Global Drug-device Combination Products Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 30: Global Drug-device Combination Products Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 31: North America Drug-device Combination Products Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 32: North America Drug-device Combination Products Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 33: North America Drug-device Combination Products Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 34: North America Drug-device Combination Products Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 35: North America Drug-device Combination Products Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 36: North America Drug-device Combination Products Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 37: North America Drug-device Combination Products Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 38: North America Drug-device Combination Products Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 39: North America Drug-device Combination Products Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 40: Europe Drug-device Combination Products Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 41: Europe Drug-device Combination Products Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 42: Europe Drug-device Combination Products Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 43: Europe Drug-device Combination Products Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 44: Europe Drug-device Combination Products Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 45: Europe Drug-device Combination Products Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 46: Europe Drug-device Combination Products Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 47: Europe Drug-device Combination Products Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 48: Europe Drug-device Combination Products Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 49: Asia Pacific Drug-device Combination Products Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 50: Asia Pacific Drug-device Combination Products Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 51: Asia Pacific Drug-device Combination Products Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 52: Asia Pacific Drug-device Combination Products Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 53: Asia Pacific Drug-device Combination Products Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 54: Asia Pacific Drug-device Combination Products Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 55: Asia Pacific Drug-device Combination Products Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 56: Asia Pacific Drug-device Combination Products Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 57: Asia Pacific Drug-device Combination Products Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 58: Latin America Drug-device Combination Products Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 59: Latin America Drug-device Combination Products Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 60: Latin America Drug-device Combination Products Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 61: Latin America Drug-device Combination Products Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 62: Latin America Drug-device Combination Products Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 63: Latin America Drug-device Combination Products Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 64: Latin America Drug-device Combination Products Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 65: Latin America Drug-device Combination Products Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 66: Latin America Drug-device Combination Products Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 67: Middle East & Africa Drug-device Combination Products Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 68: Middle East & Africa Drug-device Combination Products Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 69: Middle East & Africa Drug-device Combination Products Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 70: Middle East & Africa Drug-device Combination Products Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 71: Middle East & Africa Drug-device Combination Products Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 72: Middle East & Africa Drug-device Combination Products Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 73: Middle East & Africa Drug-device Combination Products Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 74: Middle East & Africa Drug-device Combination Products Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 75: Middle East & Africa Drug-device Combination Products Market Attractiveness Analysis, By End-user, 2025 to 2035